SCP Vitalife Partners (Israel) II, L.P., 10% Owner at Recro Pharma, Inc. (REPH), sold 6,208 shares at $3.03 ($19K) on 2020-12-18, disclosed to the SEC on 2020-12-22.
Open-market sale of $19k REPH by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| REPH | SELL | 2018-01-04 | $230K | — | Filing → |
| REPH | SELL | 2018-01-02 | $56K | — | Filing → |
| REPH | SELL | 2017-12-28 | $42K | — | Filing → |